Choroidal drainage good option for acute angle closure

Article

Choroidal drainage can be a safe and effective interventional procedure for patients presenting with acute angle closure secondary to Topiramate toxicity.

Choroidal drainage can be a safe and effective interventional procedure for patients presenting with acute angle closure secondary to Topiramate toxicity, according to a case report published in the December 2007 issue of the Journal of Glaucoma.

Topiramate is an anti-convulsant drug administered to treat certain types of seizures in patients with epilepsy.

Rajul Parikh and co-workers from the Christian Medical College, Vellore and the LV Prasad Eye Institute, Hyderabad, India reported the role of choroidal drainage in a patient with acute bilateral angle closure secondary to cilio-choroidal effusion with Topiramate.

Two-weeks after commencing Topiramate for the management of epilepsy, the patient developed acute bilateral angle closure secondary to cilio-choroidal effusion with lenticulo-corneal touches for which choroidal drainage was performed.

Following the procedure, the anterior chamber deepened, the corneal oedema resolved, choroidals began to resolve and intraocular pressure was controlled without medication. The researchers therefore concluded that, in patients presenting with acute angle closure secondary to Topiramate toxicity, choroidal drainage is a safe and effective interventional procedure.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.